BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23200912)

  • 1. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.
    Schmeler KM; Wilson GL; Cain K; Munsell MF; Ramirez PT; Soliman PT; Nick AM; Frumovitz M; Coleman RL; Kroll MH; Levenback CF
    Gynecol Oncol; 2013 Feb; 128(2):204-8. PubMed ID: 23200912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
    Marques de Marino P; Rial Horcajo R; Garcia Grandal T; Sanchez Hervas L; Serrano Hernando FJ; Herraiz Martinez MA; Coronado Martin PJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():90-95. PubMed ID: 30245443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
    Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
    Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quality improvement initiative to reduce venous thromboembolism on a gynecologic oncology service.
    Gonzalez R; Kurtovic K; Habib AS; Ryan ES; Foote J; Pandya D; Broadwater G; Havrilesky LJ
    Gynecol Oncol; 2021 Jul; 162(1):120-127. PubMed ID: 33994013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?
    Swift BE; Maeda A; Bouchard-Fortier G
    Gynecol Oncol; 2022 Feb; 164(2):311-317. PubMed ID: 34920887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery.
    Wright JD; Chen L; Jorge S; Burke WM; Tergas AI; Hou JY; Hu JC; Neugut AI; Ananth CV; Hershman DL
    Gynecol Oncol; 2016 Jun; 141(3):531-537. PubMed ID: 27032377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a venous thromboembolism risk assessment model in gynecologic oncology.
    Stroud W; Whitworth JM; Miklic M; Schneider KE; Finan MA; Scalici J; Reed E; Bazzett-Matabele L; Straughn JM; Rocconi RP
    Gynecol Oncol; 2014 Jul; 134(1):160-3. PubMed ID: 24796634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?
    Bouchard-Fortier G; Geerts WH; Covens A; Vicus D; Kupets R; Gien LT
    Gynecol Oncol; 2014 Aug; 134(2):228-32. PubMed ID: 24875122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery.
    Corr BR; Winter AM; Sammel MD; Chu CS; Gage BF; Hagemann AR
    Gynecol Oncol; 2015 Sep; 138(3):501-6. PubMed ID: 26186912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.
    Shi J; Ye J; Zhuang X; Cheng X; Fu R; Zhao A
    J Obstet Gynaecol Res; 2019 Mar; 45(3):657-664. PubMed ID: 30393982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: A systematic review and network meta-analysis.
    Insin P; Vitoopinyoparb K; Thadanipon K; Charakorn C; Attia J; McKay GJ; Thakkinstian A
    Gynecol Oncol; 2021 Apr; 161(1):304-313. PubMed ID: 33563489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic use of low molecular weight heparin in combination with graduated compression stockings in post-operative patients with gynecologic cancer].
    Zheng H; Gao Y; Yan X; Gao M; Gao W
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):39-42. PubMed ID: 24685085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer.
    Cain K; Schmeler KM; Langley G; Max O; Ramirez PT; Levenback CF
    Gynecol Oncol; 2012 Oct; 127(1):18-21. PubMed ID: 22813886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies.
    Nguyen JMV; Gien LT; Covens A; Kupets R; Osborne RJ; Sadeghi M; Nathens AB; Vicus D
    Int J Gynecol Cancer; 2022 Jan; 32(1):55-61. PubMed ID: 32571889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
    Carbajal-Mamani SL; Dideban B; Schweer D; Balavage KT; Chuang L; Wang Y; Wang S; Lee JH; Amaro B; Cardenas-Goicoechea J
    J Robot Surg; 2021 Jun; 15(3):343-348. PubMed ID: 32592139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery.
    Kukreja JE; Levey HR; Scosyrev E; Kiernan M; Berrondo C; McNamee C; Wu G; Joseph JV; Ghazi A; Rashid H; Dozier A; Messing EM
    Urol Oncol; 2015 Sep; 33(9):387.e7-16. PubMed ID: 25637953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.
    Graul A; Latif N; Zhang X; Dean LT; Morgan M; Giuntoli R; Burger R; Kim S; Ko E
    Int J Gynecol Cancer; 2017 Mar; 27(3):581-587. PubMed ID: 28187092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular weight vs. unfractionated heparin for prevention of venous thromboembolism in general surgery: a meta-analysis.
    Nair P; Trivedi R; Hu P; Zhang Y; Merchant AM
    Updates Surg; 2021 Feb; 73(1):75-83. PubMed ID: 32880870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
    Zhu J; Jiang H; Marshall B; Li J; Tang X
    Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.